Management strategies and possible risk factors for ventricular septal defects after transcatheter aortic valve replacement: Case series from a single center and review of literature

Cardiovasc Revasc Med. 2017 Sep;18(6):462-470. doi: 10.1016/j.carrev.2017.04.003. Epub 2017 Apr 8.

Abstract

Development of membranous ventricular septal defects (VSD) is a rare complication of transcatheter aortic valve replacements (TAVR), and is recognized using intraoperative and postoperative imaging. We present two cases of this rare but serious complication; one was successfully managed conservatively and the other with valve-in-valve therapy. Management strategies for post-TAVR VSDs varies, but should be individualized to the clinical scenario. We performed a literature search and sought to identify various risk factors which may predispose patients to the development of VSD after TAVR.

Keywords: Aortic stenosis; Transcatheter aortic valve replacement; Ventricular septal defect.

Publication types

  • Review

MeSH terms

  • Aortic Valve / surgery*
  • Aortic Valve Stenosis / surgery*
  • Heart Septal Defects, Ventricular / surgery*
  • Heart Valve Prosthesis / adverse effects
  • Humans
  • Risk Factors
  • Transcatheter Aortic Valve Replacement* / methods